Company profile
Capricor Therapeutics, Inc.
Pipeline4 assets
- DeramiocelCAP-1002 / allogeneic CDCs / Neuromuscular diseaseDuchenne muscular dystrophy (DMD)Phase 3in progressBecker muscular dystrophy (BMD)Preclinicalin progress
- StealthX™STX-S / Exosome-based vaccine / Infectious diseaseSARS-CoV-2Phase 1in progress
- StealthX™Therapeutic ExosomesEvaluatingPreclinicalin progress
- CDC-ExosomesExosome Platform / Neuromuscular diseaseDuchenne muscular dystrophyPreclinicalin progress
Latest news13 items
All newsCapricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
Presentation / Abstract • Phase 3